T/CEMA 053-2025 Active Group standards

T/CEMA 053-2025 Expert Consensus on the Clinical Application of Niuhuang Shangqing Capsule

Publish Date: 2025-12-31 Implement Date: 2025-12-31 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CEMA 053-2025

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Video, pulse system equipment

ICS Name: Drugs

Publish Date: 2025-12-31

Implement Date: 2025-12-31

Scope

This document provides guidelines on the clinical application of Niuhuang Shangqing Capsules, including the syndrome characteristics, disease stages, dosage, treatment course, concomitant medication, precautions, usage recommendations, and contraindications. This document is applicable to clinicians (traditional Chinese medicine, Western medicine, and integrated Chinese and Western medicine specialists) and pharmacists in medical and health institutions at all levels across China, providing guidance and reference for the rational use of Niuhuang Shangqing Capsules. By formulating expert consensus, we aim to clarify the advantages of Niuhuang Shangqing Capsules in treatment, dosage and treatment course characteristics, and safety issues, with the goal of improving clinical efficacy, promoting rational drug use, and reducing medication risks.